The biopharma industry and the U.S. Food and Drug Administration face a busy December with nine companies awaiting approval decisions.
The U.S. Food and Drug Administration approved Bayer AG’s hormonal contraceptive device Kyleena to prevent pregnancy for up to five years.
Bayer AG’s Essure birth control implant should carry the strongest safety warning label, U.S. regulators said on Monday, following thousands of complaints about the device. The U.S. Food and Drug Administration also asked the German drugmaker to conduct a post-market study of the device. Essure, acquired by Bayer in 2013, has been the target of […]
(Reuters Health) – U.S. public health funding – which covers things like disease prevention, cancer screenings, contraceptives and vaccines – has been steadily falling in recent years and is expected to keep going down, a recent study projects. Real, inflation-adjusted public health expenditures surged from $39 per capita in 1960 to $281 per capita in […]
Women implanted with Bayer AG’s Essure permanent contraception device were more than 10 times more likely to require post-procedure surgery than those who underwent laparoscopic sterilization, a study published on Tuesday found. The findings could cast additional doubt on the safety of the Bayer device, which was approved in 2002 as an alternative to surgical […]